The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) to predict succeeding onset of immune-related adverse events (irAEs).
 
Rika Kizawa
No Relationships to Disclose
 
Yuji Miura
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Ono Pharmaceutical
 
Yasuhiro Oda
No Relationships to Disclose
 
Yukiko Nagaoka
No Relationships to Disclose
 
Yukinori Ozaki
No Relationships to Disclose
 
Chihiro Kondoh
No Relationships to Disclose
 
Shuhei Moriguchi
No Relationships to Disclose
 
Yui Takahashi
No Relationships to Disclose
 
Kazumasa Ogawa
No Relationships to Disclose
 
Yuko Tanabe-Hashimoto
No Relationships to Disclose
 
Shuichi Taniguchi
No Relationships to Disclose
 
Toshikazu Okaneya
No Relationships to Disclose
 
Akiko Kishi
No Relationships to Disclose
 
Nobukazu Hayashi
No Relationships to Disclose
 
Kazuma Kishi
Honoraria - AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Consulting or Advisory Role - Ono Pharmaceutical
Speakers' Bureau - Chugai Pharma; Ono Pharmaceutical
 
Toshimi Takano
Honoraria - Daiichi Sankyo; Eisai; Kyowa Hakko Kirin
Research Funding - Chugai Pharma; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Jun Masuda
No Relationships to Disclose